Clayton Pharmaceuticals and VistaPharm Receive FDA Approval for Sucralfate Oral Suspension
EXTON, PA — Clayton Pharmaceuticals announced that they recently received FDA approval for Sucralfate Oral Suspension with Competitive Generic Therapy (CGT) designation.
Clayton Pharmaceuticals and VistaPharm Receive FDA Approval for Sucralfate Oral Suspension Read More